Publication | Open Access
Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies.
246
Citations
0
References
1986
Year
Lymphocyte DevelopmentHumoral ResponseImmunologyImmune RegulationPathologyBlood CellAntigen ProcessingImmune SystemImmunotherapyHematologyUnique SubpopulationLymphoid NeoplasiaAutoimmune DiseaseB CellsAutoimmunityHumoral ImmunityCell BiologyNovel SubpopulationMajor Lymphoid SubpopulationDevelopmental BiologyHuman Fetal SpleenImmune Cell DevelopmentDevelopmental ImmunologyMedicineCell Surface PhenotypeCell Development
Examination of the cell surface phenotype of fetal splenic lymphocytes demonstrated a major, novel subpopulation of B cells that co-express Leu-1 (CD5) in addition to B cell differentiation antigens (Leu-1+ B cells). These cells are similar to some conventional B cells in that they express HLA-DR, Leu-12, and B1, as well as both immunoglobulin (Ig) M and IgD. They comprise 40 to 60% of total splenic B cells in the fetus but are infrequent in fetal liver and adult spleen. Fetal Leu-1+ B cells do not respond to pokeweed mitogen with either proliferation or Ig secretion, and in contrast to the murine counterpart, Ly-1 B cells, they do not constitutively produce Ig. Leu-1+ B cells were incapable of augmenting Ig production of Leu-1- B cells when suboptimal numbers of T cells were present; however, they did require the presence of T cells to secrete antibody. They do not cap either the CD5 protein or surface Ig. These cells are a unique subpopulation of fetal splenic B cells that do not function as conventional B cells. Their role in the humoral immune response is unknown. They may represent the normal stage of B cell development, which is reflected in the phenotype of B cell CLL cells.